Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
New Centre for Medicines Research Report from Clarivate Indicates Drug Development Timelines are Shortest Since 2013 2020-09-24 16:15
AID 2020 to Launch New Activities & Zones 2020-09-24 15:00
New Development Bank prices USD 2 billion benchmark bond to further support COVID emergency response 2020-09-24 12:55
Isagenix Names Sharron Walsh CEO To Lead Company Growth 2020-09-24 12:30
AID 2020 to Launch New Activities & Zones 2020-09-24 10:45
Macrogen, K-Quarantine System "Smart Mobile Lab" Exported to Indonesia 2020-09-24 09:00
Samsung Biologics signs strategic partnership with Kanaph Therapeutics to develop treatment for retinal diseases 2020-09-24 08:00
SEMI-NBMC Invites White Paper Proposals for Funding of Human Monitoring Innovations 2020-09-24 07:11
ImmVira Announces US$10 million Strategic Series B Plus Financing with SIIC Capital 2020-09-24 00:09
Insilico releases Pandomics, AI-powered platform for Novel Therapeutic Target Discovery 2020-09-23 22:00
Ping An Good Doctor launches "Ping An Doctor Home" for Strategy + Product Dual Upgrade 2020-09-23 21:51
Avigan® Shows Promising Results in Treatment of COVID Patients in Japan 2020-09-23 21:26
PolyU launches the first dedicated interdisciplinary master programme in medical physics to nurture future clinical and academic talents in the field 2020-09-23 20:45
Ping An Unveils Health Care Ecosystem Strategy 2020-09-23 20:44
New NCCN Resource for Understanding Childhood Leukemia 2020-09-23 20:35
Johnson & Johnson Initiates Pivotal Global Phase 3 Clinical Trial of Janssen's COVID-19 Vaccine Candidate 2020-09-23 19:25
Frost & Sullivan Recognizes Xenex with 2020 Global Company of the Year Award; LightStrike Robots Dominate Healthcare Room Disinfection Devices Market 2020-09-23 19:00
OrbusNeich® Announces China Approval for COMBO® Coronary Stent 2020-09-23 16:00
iHerb Meeting Increased Worldwide Demand for Vitamin D and C 2020-09-23 15:00
Minoryx Therapeutics and Sperogenix Therapeutics enter into an exclusive license agreement to develop and commercialize leriglitazone in mainland China, Hong Kong and Macau 2020-09-23 15:00
1 626 627 628 629 630 1504